EMST in Patients Undergoing CRT for HNCA (NCT03916809)
Impact of Expiratory Muscle Strength Training (EMST) on Swallowing Function in Persons Undergoing Radiotherapy With or Without Chemotherapy (CRT) for Cancers of the Head and Neck (HNCA)
🩺 Plain-English Summary (8th-Grade Level)
This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on maintenance of safe and efficient oropharyngeal swallow function in persons with cancer of the head and neck (HNCA) undergoing treatment with radiation therapy or chemoradiotherapy (RT/CRT).
Who can join: Review the eligibility criteria below.
Location: University of Wisconsin Milwaukee — Milwaukee, Wisconsin
Age range: 18 Years
🧪 Interventions in This Study
- EMST (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- University of Wisconsin Milwaukee — Milwaukee, Wisconsin
- Froedtert Hospital — Milwaukee, Wisconsin
📞 Contact the Study Coordinator
Phone: (414) 229-6719
Email: pauloski@uwm.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Head and Neck Neoplasms
- Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689) — La Jolla, California
- Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC) — Orlando, Florida
- Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC — Chicago, Illinois
- Molecular and Genomic Profiling of Head and Neck Tumors — The Bronx, New York
- Head and Neck Cancer Study Project in the Geriatric Population — Providence, Rhode Island
Explore by condition: All Head and Neck Neoplasms clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.